DUKE UNIVERSITY MEDICAL CENTER 
Department of Microbiology 
and Immunology 
November 9, 1982 
Dr. William J. Gartland 
ORDA 
B1 dg. 31 , Room 4A52 
Bethesda, Maryland 20205 
Dear Dr. Gartland: 
We have had very few problems with the current Guidelines for 
Recombinant DNA Research. We have a standing committee which concerns 
itself only with recombinant DNA and is not part of a general safety 
committee on campus. The IBC was set up in this way by the University. 
Since the NIH downgraded most cloning experiments using E_. col i K12 
derivatives, the IBC has had very little to do except answer questions 
by investigators as there are no experiments on-going which are not 
being carried out in this system. Our IBC is like the Maytag repairman. 
We're waiting for projects to review. 
I hope these comments have been of some help. 
Sincerely, 
Vickers Burdett, Ph.D. 
Chairperson, IBC 
Assistant Professor of Microbiology 
VB : dw 
Box 3020 • Durham, North Carolina 27710 • Telephone (919) 684-2566 
[538] 
